Market cap
₹28 Cr
Revenue (TTM)
₹994 Cr
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
3.5 %
| Anil | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
28 | 17,996 | 15,439 | 12,449 | 7,048 |
Revenue (₹ Cr) |
994 | 6,643 | 14,593 | 38,840 | 926 |
Net Profit (₹ Cr) |
-0.21 | 804.37 | 1,434.33 | 1,227.53 | 35.13 |
Net Margin (%) |
-0.02 | 11.74 | 9.69 | 3.14 | 3.76 |
RoE (%) |
-0.05 | 13.10 | 16.37 | 16.62 | 4.40 |
Price to Earnings |
-- | 22.62 | 10.78 | 26.78 | 198.19 |
Price-To-Book |
0.09 | 2.78 | 1.84 | 1.37 | 4.42 |
Income Statement (₹ Cr)
| Anil | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1,226.71 | 2,594.59 | 5,780.46 | 15,357.73 | 100.30 |
|
Total Income
|
1,229.71 | 2,628.99 | 5,824.10 | 15,513.06 | 100.46 |
|
Total Expenditure
|
1,027.76 | 2,135.36 | 5,278.46 | 14,516.76 | 86.19 |
|
EBITDA
|
198.95 | 459.23 | 502.00 | 840.97 | 14.11 |
|
Depreciation
|
15.54 | 66.07 | 97.95 | 249.61 | 1.00 |
|
EBIT
|
183.41 | 393.16 | 404.05 | 591.36 | 13.11 |
|
Interest
|
103.22 | 27.53 | 85.41 | 451.20 | 4.79 |
|
Other Income
|
3.00 | 34.40 | 43.64 | 155.33 | 0.16 |
|
Exceptional Items
|
-0.01 | -- | -- | 25.00 | -- |
|
Profit before Tax
|
83.18 | 404.49 | 362.28 | 318.89 | 8.48 |
|
Provision for Tax
|
27.43 | 130.22 | 61.85 | 143.67 | 3.30 |
|
Profit after Tax
|
55.75 | 274.27 | 300.43 | 175.22 | 5.18 |
Liabilities (₹ Cr)
| Anil | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
392.62 | 1,614.79 | 2,090.91 | 2,387.33 | 27.55 |
|
Minority Interest
|
1.50 | 2.45 | 2.21 | 1,039.51 | -- |
|
Non-Current Liabilities
|
498.48 | 142.03 | 415.08 | 1,226.99 | 7.36 |
|
Current Liabilities
|
524.79 | 706.20 | 2,791.61 | 9,477.19 | 45.58 |
|
Total Liabilities
|
1,415.88 | 2,465.47 | 5,321.37 | 14,131.02 | 80.48 |
Assets (₹ Cr)
| Anil | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
626.60 | 1,406.76 | 1,979.67 | 4,224.77 | 19.57 |
|
Current Assets
|
789.29 | 1,058.71 | 3,209.01 | 9,906.25 | 60.92 |
|
Total Assets
|
1,415.88 | 2,465.47 | 5,321.37 | 14,131.02 | 80.48 |
|
Total Debt*
|
841.92 | 315.82 | 1,063.96 | 5,143.60 | 26.43 |
|
Net Current Assets
|
264.50 | 352.51 | 417.40 | 429.06 | 15.34 |
|
Contingent Liabilities
|
110.33 | 154.08 | 47.80 | 391.93 | 5.55 |
Cashflow (₹ Cr)
| Anil | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
77.38 | 400.97 | 100.22 | 437.02 | 8.59 |
|
Cash Flow from Investing Activities
|
-135.33 | -374.78 | -325.99 | -190.03 | -4.41 |
|
Cash from Financing Activities
|
56.57 | -39.34 | 166.28 | -221.18 | -4.11 |
|
Net Cash Inflow / Outflow
|
-1.38 | -13.15 | -59.49 | 25.81 | 0.07 |
Ratios
Profitability Ratios
| Anil | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
ROCE (%)
|
16.54 | 26.44 | 15.51 | 10.57 | 26.11 |
|
ROE (%)
|
16.98 | 20.67 | 15.21 | 7.60 | 20.30 |
|
ROA (%)
|
4.25 | 12.79 | 6.18 | 1.30 | 6.94 |
|
EBIT Margin (%)
|
16.46 | 19.03 | 9.44 | 6.49 | 14.23 |
|
Net Margin (%)
|
4.53 | 10.43 | 5.16 | 1.13 | 5.16 |
|
Cash Profit Margin (%)
|
5.70 | 12.35 | 6.61 | 2.72 | 5.68 |
Growth Ratios
| Anil | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
26.58 | -2.33 | 2.51 | 10.07 | 19.52 |
|
EBIT Growth (%)
|
16.23 | 19.95 | 21.17 | -11.29 | 4.53 |
|
Net Profit Growth (%)
|
0.87 | 21.25 | 42.52 | -36.59 | 1.87 |
|
EPS Growth (%)
|
0.92 | 13.68 | 43.15 | -70.45 | 1.77 |
|
Book Value Growth (%)
|
16.78 | 55.42 | 12.50 | 7.41 | 17.29 |
Valuation Ratios
| Anil | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Price / Earnings
|
5.63 | 16.71 | 7.48 | 111.08 | 0.00 |
|
Price / Book Value
|
0.84 | 2.83 | 1.08 | 1.61 | 0.00 |
|
Dividend Yield (%)
|
0.33 | 0.65 | 2.30 | 0.00 | -- |
|
EV/EBITDA
|
5.77 | 9.85 | 6.02 | 8.68 | 3.08 |
|
Market Cap (₹ Cr)
|
296.31 | 4,570.16 | 2,258.17 | 3,833.32 | 0.00 |
Solvency Ratios
| Anil | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Debt to Equity
|
2.14 | 0.20 | 0.51 | 2.16 | 0.96 |
|
Short term debt to equity ratio
|
0.75 | 0.16 | 0.35 | 1.51 | 0.73 |
|
Current Ratio
|
1.50 | 1.50 | 1.15 | 1.05 | 1.34 |
|
Quick Ratio
|
0.96 | 0.89 | 0.68 | 0.62 | 0.64 |
|
Interest Coverage
|
1.81 | 15.69 | 5.24 | 1.71 | 2.77 |
Operating Efficiency Ratios
| Anil | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
36.52 | 17.01 | 22.26 | 13.33 | 15.80 |
|
Asset Turnover
|
0.95 | 1.28 | 1.24 | 1.15 | 1.46 |
|
Receivable days
|
118.34 | 58.55 | 71.36 | 44.01 | 56.68 |
|
Inventory Days
|
79.23 | 55.85 | 74.21 | 93.33 | 93.95 |
|
Payable days
|
43.67 | 80.39 | 120.50 | 98.13 | 114.11 |
|
Cash Conversion Cycle
|
153.89 | 34.00 | 25.07 | 39.21 | 36.52 |